Provided by Tiger Trade Technology Pte. Ltd.

Patrys Ltd

0.031
-0.001-3.13%
Volume:137.36K
Turnover:4K
Market Cap:20.67M
PE:-3.73
High:0.032
Open:0.031
Low:0.031
Close:0.032
52wk High:0.052
52wk Low:0.015
Shares:666.61M
Float Shares:183.00M
Volume Ratio:0.30
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.008
EPS(LYR):-0.008
ROE:-62.59%
ROA:-33.25%
PB:2.03
PE(LYR):-3.73

Loading ...

Company Profile

Company Name:
Patrys Ltd
Exchange:
ASX
Establishment Date:
2006
Employees:
10
Office Location:
168 Stirling Highway,Nedlands,Western Australia,Australia
Zip Code:
6009
Fax:
- -
Introduction:
Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates live cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1 as a treatment for metastatic triple negative breast cancer and glioblastoma. In addition, it engages in developing PAT-SC1's target/antigen CD55PAT-SC1, an isoform of the membrane-bound CD55 for the treatment of gastric cancer. Patrys Limited was founded in 2006 and is based in South Melbourne, Australia.